Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL Behring
Biotech
CSL consolidates R&D team in shift toward external partners
CSL is undergoing “a strategic review of its R&D operations” designed to reduce duplication and improve efficiency, a spokesperson told Fierce.
Gabrielle Masson
Jul 7, 2025 12:44pm
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
Intellia showcases durability of one-and-done HAE option
Jun 2, 2024 8:00am
Ionis reveals oasis for HAE patients as RNA med reduces attacks
May 31, 2024 10:40am
CSL's largest ph. 3 trial ends in failure for heart attack drug
Feb 12, 2024 5:21am
Roche's executive dominoes continue to tip—Chutes & Ladders
Dec 16, 2022 9:30am
